LiveWellCumming
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
- Testosterone Replacement Therapy (TRT)
- Hormone Replacement Therapy (HRT)
Cumming, GA
Cumming has a Forsyth County exurb with rapidly growing wellness clinic demand, and peptide therapy has grown into a visible slice of the local wellness market. The clinics we track across the Collection area, Vickery, and Lake Lanier border range from physician-led longevity practices to medspa-adjacent wellness offices offering sermorelin blends and growth hormone peptides. Most local prescribers have training or admitting privileges within the Northside Forsyth network. The scene here skews toward clinics serving a young-family and corporate commuter demographic. The regulatory landscape shifted sharply in 2023 and 2024 when the FDA placed several widely prescribed peptides on its Category 2 bulk substances list, restricting which ingredients compounding pharmacies could legally source. That changed access overnight for BPC-157, CJC-1295, ipamorelin, and thymosin beta-4. Sermorelin and tesamorelin remain FDA-approved for specific indications, and reputable Cumming clinics now draw a clearer line between approved peptides and off-label research compounds than they did two years ago.
Regulatory context
Most research peptides used in regenerative medicine (BPC-157, TB-500, CJC-1295, ipamorelin) are not FDA-approved drugs. Sermorelin and tesamorelin hold FDA approvals for specific indications. The FDA placed several peptides into Category 2 on its Bulk Drug Substances Nominated for Use in Compounding list during 2023 and 2024, restricting which peptides 503A compounding pharmacies may source. Section 503A applies to traditional patient-specific compounding; Section 503B covers FDA-registered outsourcing facilities held to cGMP.
The Georgia Board of Pharmacy inspects compounding facilities under USP 795 and USP 797 standards. Non-resident pharmacies shipping peptides into Georgia must hold a non-resident pharmacy permit. The Board has taken action against pharmacies for sterile compounding deficiencies and for sourcing ingredients inconsistent with FDA rules.